Peter Wehrwein

Per episode saving of $297 during the first three years of the value-based care model were offset by $704 in payments for enhanced services to the 201 participating practices, study finds.

By giving Semglee, the interchangeable biosimilar for Lantus, a preferred spot on its formulary, the Prime Therapeutics says it is setting the stage for other interchangeables coming down the pike, including the one for Humira.

Having CMS negotiate drug prices is a policy favored by President Joe Biden and many Democrats, and it is a prominent feature of H.R. 3, also known as the Elijah Cummings Lower Drug Costs Now Act.

Results of study published in JAMA Oncology suggest that it is the period after chemotherapy when cancer patients are most vulnerable to experiencing a serious case of COVID-19.

Findings from a longitudinal study of nonalcoholic fatty liver disease patients show that mortality increased with fibrosis.

Samagh is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Growth, competition and equity were among the topics discussed at the Asembia’s 2021 Specialty Pharmacy Summit in Las Vegas this week

Michelle Booth, Pharm.D., of Magellan Rx Management, is speaking at this year's Asembia Specialty Pharmacy Summit. In this clip Booth speaks about trends in drug spend and the differences among the commercial, Medicare and Medicaid lines of business.

Heather Bonome, Pharm.D., pharmacy director at URAC, a healthcare accreditation organization, is a speaker at the 2021 Asembia Specialty Pharmacy Summit. Bonome talks about a defining telehealth, the pandemic's effect on the use of telehealth in specialty pharmacy and whether URAC might add telehealth requirements to its accrediting standards for specialty pharmacies.

Toy is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Evie Powell is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Disparities, biosimilars and digital therapeutics were among the featured topics at the meeting in Denver that had 1,900 attendees.

Michael Palantoni is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Consultant Jeffrey Casberg says biosimilars are coming on strong and that interchangeability may not be much for the products dispensed through specialty pharmacies because specialty pharmacies are often in frequent touch with physicians.

Page and Taddei-Allen of WellDyne discuss precision medicine and its implications for pharmacy management at this year's AMCP Nexus Conference

Shantanu Nundy is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

A panel discussion on prescription digital therapeutics identified them as a sweet spot for value-based agreements and collection of real-world evidence. But should they be paid for through the pharmacy benefit? And is there enough evidence available for payers and PBMs to make sound coverage and formulary decisions? For answers, stay tuned.

Joan Barrett of Axene Health Partners and Nicole Bulochnik of Optum discuss value-based care models and actuaries' involvement during this year's AMCP Nexus conference.

The Southern California Medicare Advantage health plan zeroed in on medication adherence among its Black and Latinx members and took a multifaceted approach, which included cultural humility training and pairing staff and members had language and a cultural background in common.

Melissa Hanna is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

The growing ranks of FDA-approved orphan drugs for rare diseases have saved and improved many lives. But the high-priced drugs are also a major cost burden.

Barlow spoke at AMCP Nexus about gene and cell therapy and about how payment models need to adjust to account for their high initial cost and their durable — in some cases lifetime — effects.

Loucks, manager of specialty clinical pharmacy programs and formulary at Kaiser Permanente Washington, discusses metrics that might give healthcare providers an incentive to address healthcare disparities and concrete steps that could be taken to turn the talk about addressing healthcare disparities into a reality.

If the new drug is approved, a Mayo Clinic expert on hypertrophic cardiomyopathy sees the new medication as probably being among the second-line choices for patients who don’t respond to beta blockers and calcium channel blockers.

Rachel Kotok Goldberg is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

The first panel discussion of the meeting was a window into the variety of ways that health plans are working to close health disparities.

Ann Mary Ferrie is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Harold Carter is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

In this video segment, Bhat discusses his early career as community health worker in East Baltimore and starting and leading the growth of Healthify, a company that helps healthcare organizes address the social determinants of health. Healthify has recently been acquired by Wellsky and Bhat's title is vice president of SDOH operations and sales. Bhat also discusses the sacrifices his parents made for him and his brother and their work ethic.

Manik Bhat is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.